
Moxifloxacin
Community-acquired Pneumonia, Acute Sinusitis
400mg
Moxifloxacin 400 mg tablets, a fluoroquinolone antibiotic for pneumonia, sinusitis and skin infections, the ingredient in Avelox.
Moxifloxacin is a broad-spectrum fluoroquinolone medication often identified by the well-known brand Avalox. It is used to target severe bacterial infections in the respiratory and skin systems. Avelox is the single listed product formulation.

Community-acquired Pneumonia, Acute Sinusitis
400mg
Moxifloxacin 400 mg tablets, a fluoroquinolone antibiotic for pneumonia, sinusitis and skin infections, the ingredient in Avelox.
Moxifloxacin belongs to the fluoroquinolone class of antibiotics. It is designed to act against a wide range of bacteria, making it an option when initial treatments are insufficient. Due to its specific mechanism, it is primarily used in settings where a strong systemic response is required to manage bacterial growth.
Medical providers may recommend this medication to treat Bacterial Pneumonia or Acute Sinusitis. It is also indicated for Complicated Skin and Soft Tissue Infection. This medication falls under the broader field of Antibiotics, which are used to manage various bacterial threats to systemic health.
This medication functions by disrupting the internal machinery bacteria need to thrive. It targets specific enzymes that allow the bacteria to replicate their genetic material. By inhibiting these enzymes, the medicine prevents the bacteria from multiplying, allowing the natural immune system to clear the infection more effectively.
Review all ingredients for potential sensitivities or allergies. Evaluate existing medical records, especially regarding heart rhythm conditions, tendon issues, or joint problems, as these may require clinical caution.
Common responses can include gastrointestinal discomfort or nausea. Some individuals may experience dizziness or changes in sun sensitivity. Report any severe or persistent change in physical state to a healthcare provider immediately.
Certain supplements, minerals, or other medications may interfere with absorption. Always confirm that all active treatments are compatible with this medicine to prevent reduced efficacy or adverse reactions. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
Last updated